Developer docs
API playgroundTry for free, no card

Search company profiles

Accumen

Full company profile

uuid0008mw2

Namestring
Accumen
Legal namestring
Accumen
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Accumen is a healthcare services and technology company headquartered in San Diego, California that partners with hospitals and health systems to deliver Laboratory Excellence and Comprehensive Patient Blood Management. Founded in 2011, the company historically provided consulting, operational improvement, and analytics services targeting clinical laboratory performance and transfusion medicine, supported by tuck-in acquisitions of Chi Solutions (2016), Halfpenny Technologies (2019), and 3DR Labs (2019).

Following its acquisition by hc1 in January 2025, Accumen's capabilities have been integrated into the hc1 IQ™ agentic intelligence platform, which unifies clinical intelligence, operational analytics, supply chain optimization, and market growth into a single AI-powered ecosystem. The platform comprises four modules — Clinical IQ™, Ops IQ™, Source IQ™, and Signal IQ™ — that process 12B+ lab results, 277M claims records, 89M patient profiles, and 600K clinical histories. Underlying capabilities include predictive analytics, autonomous agents, anomaly detection, supply and workflow optimization, and generative AI (Voice AI and Gen AI for dictation and workflows). Disclosed customer outcomes include $500K–$2M in test utilization savings per health system annually, 10–15% supply cost reductions, 20%+ operational efficiency improvements, and 10–20% outreach revenue growth.

The business model is enterprise SaaS and services-based, targeting large health systems and reference laboratories. The combined entity cites 450+ hospitals and health systems as customers, impacting 25M+ patient lives, with named customers including Sonora Quest Laboratories, Bon Secours Mercy Health, Quest Diagnostics, Rush University Medical Center, UNC Health, and Norman Regional. Specific pricing is not publicly disclosed. Following the January 2025 acquisition, Accumen operates as a subsidiary within hc1's broader healthcare AI strategy; the $6.25M funding round backing the deal was led by Health Cloud Capital and A1 Health Ventures.

Short descriptiontext

Accumen partners with hospitals and health systems to deliver laboratory excellence and comprehensive patient blood management services. Founded in 2011 and acquired by hc1 in 2025, its capabilities now integrate into hc1's AI-powered hc1 IQ lab intelligence platform serving 450+ health systems.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
healthcare diagnostics analytics, laboratory intelligence platform, patient blood management, clinical decision support, healthcare AI solutions
Industry2 codes
1Lab Analytics, Utilization Management & Operational Intelligence
CodeHLACAMAKPrimaryYes
2Enterprise Integration Engines & Interface Management (HL7 v2/X12/API)
CodeHLACABACPrimaryNo
NAICS code1 code
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Healthcare Diagnostics Analytics Software
Social media profiles1 record
Cost components5 values
Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Accumen partners with hospitals and health systems to deliver Laboratory Excellence and Comprehensive Patient Blood Management. Following its acquisition by hc1, Accumen's operations now reside within the hc1 IQ™ agentic intelligence platform, an AI-powered ecosystem that unifies clinical intelligence, operational analytics, supply chain optimization, and market growth solutions to transform lab data into strategic advantage for health systems.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Accumen, now part of hc1 following acquisition, operates the hc1 IQ™ platform — a unified agentic intelligence platform that transforms lab data into strategic advantage. The platform consists of four integrated modules: Clinical IQ™ for clinical intelligence and care gap closure, Ops IQ™ for operational analytics and workflow optimization, Source IQ™ for supply chain optimization and contract management, and Signal IQ™ for market intelligence and revenue growth. These modules share a unified data layer processing 12B+ lab results, 277M claims records, and 89M patient profiles, enabling healthcare organizations to close care gaps, cut costs, and drive growth across their operations.

Product and service5 records
1hc1 IQ™
CategoryHealthcare diagnostics analytics platform
Description

The agentic intelligence platform that unifies clinical intelligence, operational analytics, supply chain optimization, and market growth into a single AI-powered ecosystem. Transforms lab data into strategic advantage for health systems by closing care gaps, cutting costs, and driving growth.

2Clinical IQ™
CategoryClinical intelligence software
Description

Clinical intelligence module that applies clinician-built AI to identify at-risk patients, reduce unnecessary testing, and ensure the right test reaches the right patient at the right time. Reduces unnecessary test orders by 15-30% and identifies undiagnosed chronic conditions early.

3Ops IQ™
CategoryLab operations analytics software
Description

Operational analytics module delivering real-time visibility into turnaround times, staffing efficiency, and workflow bottlenecks. AI predicts problems before they impact patient care, improving turnaround time by 20%+ and maximizing analyzer utilization.

4Source IQ™
CategoryLab supply chain optimization software
Description

Supply chain optimization module combining market intelligence, utilization analytics, and AI-powered forecasting. Achieves average 10-15% reduction in supply costs through vendor-agnostic contract optimization and predictive inventory management.

5Signal IQ™
CategoryMarket intelligence and outreach analytics software
Description

Market growth and data intelligence module analyzing market signals, referral patterns, and client behavior. Helps identify high-value acquisition targets, predict and prevent client attrition, and increase outreach revenue 10-20%.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

hc1 completed a $6.25 million funding round following its acquisition of Accumen. Accumen was acquired by hc1 and its technology/operations are now integrated into hc1's AI-powered lab intelligence platform.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

CliniSys delivers laboratory information systems used by hospital and reference labs across multiple geographies. Its end-to-end LIS and lab informatics focus makes it a comparable direct competitor in the lab intelligence space.

TypeEmerging player
Description

LeanDNA applies analytics and AI to supply chain and operational optimization in lab-adjacent and healthcare environments. It partially overlaps with hc1 IQ's Source IQ and Ops IQ modules for cost reduction and workflow optimization.

TypeDirect peer
Description

Sunquest provides laboratory information systems (LIS) and diagnostic informatics used by hospitals and reference labs. It directly competes with hc1 IQ's lab intelligence, LIS connectivity, and operational analytics positioning.

TypeBroad incumbent
Description

Siemens Healthineers provides Atellica laboratory diagnostics and analytics used in hospital and reference labs. It competes with hc1 IQ by combining analyzer instrumentation, middleware, and operational intelligence in a vertically integrated offering.

TypeDirect peer
Description

LabVantage provides laboratory information management systems (LIMS) used in clinical and analytical labs. It competes with hc1 IQ in lab informatics, workflow optimization, and operational analytics for hospital and reference laboratories.

TypeBroad incumbent
Description

Bio-Rad provides clinical diagnostics and laboratory quality management products used by hospital and reference labs. While primarily an instrumentation and controls vendor, its lab quality and data offerings create partial overlap with hc1 IQ's operational and quality analytics.

TypeBroad incumbent
Description

Oracle Health's Cerner Millennium includes laboratory and pathology solutions used across large health systems. Its installed base and enterprise IT bundling position it as a broad incumbent alternative to standalone lab intelligence platforms like hc1 IQ.

TypeDirect peer
Description

Xifin offers cloud-based laboratory analytics, revenue cycle management, and outreach solutions for clinical labs and hospitals. It overlaps directly with hc1 IQ's Signal IQ and Source IQ modules serving health system labs.

TypeBroad incumbent
Description

Roche Diagnostics delivers laboratory analyzers, lab informatics, and clinical decision support through its diagnostics division. It overlaps with hc1 IQ in lab data analytics and clinical intelligence for health systems.

TypeBroad incumbent
Description

Epic's Beaker LIS module provides laboratory and pathology functionality within its dominant EHR platform. As the leading hospital EHR, Epic competes with hc1 IQ by embedding lab analytics and LIS connectivity into its broader enterprise suite.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Accumen

Healthcare Diagnostics Analytics Softwareaccumen.com

Accumen partners with hospitals and health systems to deliver laboratory excellence and comprehensive patient blood management services. Founded in 2011 and acquired by hc1 in 2025, its capabilities now integrate into hc1's AI-powered hc1 IQ lab intelligence platform serving 450+ health systems.

What Accumen does

Accumen is a healthcare services and technology company headquartered in San Diego, California that partners with hospitals and health systems to deliver Laboratory Excellence and Comprehensive Patient Blood Management. Founded in 2011, the company historically provided consulting, operational improvement, and analytics services targeting clinical laboratory performance and transfusion medicine, supported by tuck-in acquisitions of Chi Solutions (2016), Halfpenny Technologies (2019), and 3DR Labs (2019).

Following its acquisition by hc1 in January 2025, Accumen's capabilities have been integrated into the hc1 IQ™ agentic intelligence platform, which unifies clinical intelligence, operational analytics, supply chain optimization, and market growth into a single AI-powered ecosystem. The platform comprises four modules — Clinical IQ™, Ops IQ™, Source IQ™, and Signal IQ™ — that process 12B+ lab results, 277M claims records, 89M patient profiles, and 600K clinical histories. Underlying capabilities include predictive analytics, autonomous agents, anomaly detection, supply and workflow optimization, and generative AI (Voice AI and Gen AI for dictation and workflows). Disclosed customer outcomes include $500K–$2M in test utilization savings per health system annually, 10–15% supply cost reductions, 20%+ operational efficiency improvements, and 10–20% outreach revenue growth.

The business model is enterprise SaaS and services-based, targeting large health systems and reference laboratories. The combined entity cites 450+ hospitals and health systems as customers, impacting 25M+ patient lives, with named customers including Sonora Quest Laboratories, Bon Secours Mercy Health, Quest Diagnostics, Rush University Medical Center, UNC Health, and Norman Regional. Specific pricing is not publicly disclosed. Following the January 2025 acquisition, Accumen operates as a subsidiary within hc1's broader healthcare AI strategy; the $6.25M funding round backing the deal was led by Health Cloud Capital and A1 Health Ventures.

Accumen firmographics

Firmographics
Name
Accumen
Legal name
Accumen
Website
http://www.accumen.com/
Company type
Private
Founded year
2011
Operating status
Acquired
Headcount range
101–250 employees
Short description
Accumen partners with hospitals and health systems to deliver laboratory excellence and comprehensive patient blood management services. Founded in 2011 and acquired by hc1 in 2025, its capabilities now integrate into hc1's AI-powered hc1 IQ lab intelligence platform serving 450+ health systems.
Ownership category
akta.pro rank

Accumen industry classification

Industry
Product category
Healthcare Diagnostics Analytics Software
NAICS
Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Lab Analytics, Utilization Management & Operational Intelligence (HLACAMAK)
akta.pro secondary industry
Enterprise Integration Engines & Interface Management (HL7 v2/X12/API) (HLACABAC)

Keywords

  • Healthcare diagnostics analytics
  • Laboratory intelligence platform
  • Patient blood management
  • Clinical decision support
  • Healthcare AI solutions

Where Accumen is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Markets served

Accumen business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales

Accumen product offering

Product offering

Core offering

Accumen partners with hospitals and health systems to deliver Laboratory Excellence and Comprehensive Patient Blood Management. Following its acquisition by hc1, Accumen's operations now reside within the hc1 IQ™ agentic intelligence platform, an AI-powered ecosystem that unifies clinical intelligence, operational analytics, supply chain optimization, and market growth solutions to transform lab data into strategic advantage for health systems.

Product overview

Accumen, now part of hc1 following acquisition, operates the hc1 IQ™ platform — a unified agentic intelligence platform that transforms lab data into strategic advantage. The platform consists of four integrated modules: Clinical IQ™ for clinical intelligence and care gap closure, Ops IQ™ for operational analytics and workflow optimization, Source IQ™ for supply chain optimization and contract management, and Signal IQ™ for market intelligence and revenue growth. These modules share a unified data layer processing 12B+ lab results, 277M claims records, and 89M patient profiles, enabling healthcare organizations to close care gaps, cut costs, and drive growth across their operations.

Differentiator

Problem solved

Functional benefit

Products and services

  • hc1 IQ™ The agentic intelligence platform that unifies clinical intelligence, operational analytics, supply chain optimization, and market growth into a single AI-powered ecosystem. Transforms lab data into strategic advantage for health systems by closing care gaps, cutting costs, and driving growth.
  • Clinical IQ™ Clinical intelligence module that applies clinician-built AI to identify at-risk patients, reduce unnecessary testing, and ensure the right test reaches the right patient at the right time. Reduces unnecessary test orders by 15-30% and identifies undiagnosed chronic conditions early.
  • Ops IQ™ Operational analytics module delivering real-time visibility into turnaround times, staffing efficiency, and workflow bottlenecks. AI predicts problems before they impact patient care, improving turnaround time by 20%+ and maximizing analyzer utilization.
  • Source IQ™ Supply chain optimization module combining market intelligence, utilization analytics, and AI-powered forecasting. Achieves average 10-15% reduction in supply costs through vendor-agnostic contract optimization and predictive inventory management.
  • Signal IQ™ Market growth and data intelligence module analyzing market signals, referral patterns, and client behavior. Helps identify high-value acquisition targets, predict and prevent client attrition, and increase outreach revenue 10-20%.

Companies that use Accumen

Customer profile

Ideal customer profiles1 record

Accumen technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Accumen partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • hc1coreOthershc1 completed a $6.25 million funding round following its acquisition of Accumen. Accumen was acquired by hc1 and its technology/operations are now integrated into hc1's AI-powered lab intelligence platform.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Accumen competitors and assessment

Company assessment

Direct peers

  • CliniSys: CliniSys delivers laboratory information systems used by hospital and reference labs across multiple geographies. Its end-to-end LIS and lab informatics focus makes it a comparable direct competitor in the lab intelligence space.
  • Sunquest Information Systems: Sunquest provides laboratory information systems (LIS) and diagnostic informatics used by hospitals and reference labs. It directly competes with hc1 IQ's lab intelligence, LIS connectivity, and operational analytics positioning.
  • LabVantage Solutions: LabVantage provides laboratory information management systems (LIMS) used in clinical and analytical labs. It competes with hc1 IQ in lab informatics, workflow optimization, and operational analytics for hospital and reference laboratories.
  • Xifin: Xifin offers cloud-based laboratory analytics, revenue cycle management, and outreach solutions for clinical labs and hospitals. It overlaps directly with hc1 IQ's Signal IQ and Source IQ modules serving health system labs.

Emerging players

  • LeanDNA: LeanDNA applies analytics and AI to supply chain and operational optimization in lab-adjacent and healthcare environments. It partially overlaps with hc1 IQ's Source IQ and Ops IQ modules for cost reduction and workflow optimization.

Broad incumbents

  • Siemens Healthineers: Siemens Healthineers provides Atellica laboratory diagnostics and analytics used in hospital and reference labs. It competes with hc1 IQ by combining analyzer instrumentation, middleware, and operational intelligence in a vertically integrated offering.
  • Bio-Rad Laboratories: Bio-Rad provides clinical diagnostics and laboratory quality management products used by hospital and reference labs. While primarily an instrumentation and controls vendor, its lab quality and data offerings create partial overlap with hc1 IQ's operational and quality analytics.
  • Oracle Health (Cerner): Oracle Health's Cerner Millennium includes laboratory and pathology solutions used across large health systems. Its installed base and enterprise IT bundling position it as a broad incumbent alternative to standalone lab intelligence platforms like hc1 IQ.
  • Roche Diagnostics: Roche Diagnostics delivers laboratory analyzers, lab informatics, and clinical decision support through its diagnostics division. It overlaps with hc1 IQ in lab data analytics and clinical intelligence for health systems.
  • Epic Systems (Beaker): Epic's Beaker LIS module provides laboratory and pathology functionality within its dominant EHR platform. As the leading hospital EHR, Epic competes with hc1 IQ by embedding lab analytics and LIS connectivity into its broader enterprise suite.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Accumen social profiles

Digital presence

Accumen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Accumen leadership team

Management profile

Number of profiles

Profiles3 records

Accumen funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Accumen M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Accumen

What does Accumen do?

Accumen partners with hospitals and health systems to deliver Laboratory Excellence and Comprehensive Patient Blood Management. Following its acquisition by hc1, Accumen's operations now reside within the hc1 IQ™ agentic intelligence platform, an AI-powered ecosystem that unifies clinical intelligence, operational analytics, supply chain optimization, and market growth solutions to transform lab data into strategic advantage for health systems.

Is Accumen a public or private company?

Accumen is a private company. It is classified as corporate owned and is currently acquired.

When was Accumen founded?

Accumen was founded in 2011. It employs 101 to 250 people.

Where is Accumen based?

Accumen is headquartered in San Diego, United States, in the North America region.

Who are Accumen's main competitors?

Direct peers on record are CliniSys, Sunquest Information Systems, LabVantage Solutions and Xifin. LeanDNA is listed as an emerging player. Broad incumbents are Siemens Healthineers, Bio-Rad Laboratories, Oracle Health (Cerner), Roche Diagnostics and Epic Systems (Beaker).

Does Accumen have an API?

No public API is recorded for Accumen.

What industry is Accumen in?

Accumen's product category is Healthcare Diagnostics Analytics Software. Its primary akta.pro industry code is HLACAMAK, Lab Analytics, Utilization Management & Operational Intelligence, with a secondary code of HLACABAC, Enterprise Integration Engines & Interface Management (HL7 v2/X12/API). Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireAccumen Creates Employee Appreciation Day to Honor and Acknowledge Team MembersAccumen and 3DR Labs held Employee Appreciation Day on April 7, 2023, to honor team members. Accumen serves over 1,000 healthcare systems and 4,000 physicians, while 3DR Labs processes more than 400,000 patient cases annually for over 900 clients.GlobeNewswireAccumen Wins Healthcare Company of the YearAccumen was named Healthcare Company of the Year 2022 by The Healthcare Insights for its lab and clinical transformation services. The company reports over $300M in total cost savings for customers, including 15-25% average lab cost savings and $130M in annualized supply chain savings.GlobeNewswireAccumen Appoints Distinguished Hematologist-Oncologist, Patricia Ford, MD, to its Medical Advisory BoardAccumen appointed Patricia Ford, MD, to its Comprehensive Patient Blood Management Medical Advisory Board. Dr. Ford will guide clinical transformation services and solution teams implementing cPBM programs nationwide. She currently directs stem cell transplant and bloodless medicine at the University of Pennsylvania Health System.GlobeNewswireAccumen Appoints Esteemed Cardiac Surgeon and Patient Blood Management Leader, Pierre Tibi, MD, to its Medical Advisory BoardPierre Tibi, MD, was appointed to Accumen's Comprehensive Patient Blood Management Medical Advisory Board. He will guide the company's Clinical Transformation Services and MyBloodHealth program, bringing over 10 years of leadership in patient blood management. He previously served as President of SABM and is now on its board.GlobeNewswireAccumen And Clinisys Partner To Provide Expert Resources To Enhance Lab Outreach Capabilities That Help Improve Business PerformanceAccumen and Clinisys announced a multi-year partnership to provide enhanced data analysis, outreach services, and operational efficiencies for laboratory customers. The collaboration initially targets Clinisys' Atlas Outreach solution, which aims to reduce write-offs and test turnaround times. The partnership seeks to help labs grow profitable outreach programs amid industry challenges.GlobeNewswireRenowned Patient Blood Management Expert, Sherri Ozawa, RN, MSN, Promoted to Director of Clinical Operations and Delivery at AccumenSherri Ozawa, RN, MSN, was promoted to director of clinical operations and delivery at Accumen, managing over 80 patient blood management programs. She previously founded and directed a cPBM program at Englewood Health for 25 years and is a founding member of SABM.GlobeNewswireAccumen Named One of the Top 10 Most Promising Healthcare Supply Chain Management Solution Companies for 2022Accumen was named one of the top 10 most promising healthcare supply chain management solution companies for 2022. The company provides supply chain and strategic sourcing services to over 1,000 U.S. hospitals and 4,000 physician practices and clinics. Its team aims to reduce costs and mitigate supply disruptions.GlobeNewswireAccumen Patient Blood Management leader wins SABM's 21st President's AwardTiffany Hall, Director of Clinical Technology at Accumen, received the Society for the Advancement of Patient Blood Management's 21st President's Award for outstanding contributions to patient blood management. Accumen's cPBM mission is to make comprehensive patient blood management the standard of care for hospitals.GlobeNewswireAccumen appoints highly regarded physician to Medical Advisory CouncilAndrew Fletcher, MD, MBA, CPE, CHCQM, FCAP, was appointed to Accumen's Medical Advisory Council, specializing in lab stewardship. He will focus on improving laboratory services, patient safety, test utilization, and hospital lab quality. Fletcher is a board-certified anatomic/clinical pathologist and former medical director of ARUP Consultative Services.GlobeNewswireAccumen Completes Halfpenny Technologies Integration into Accumen Technology SolutionsAccumen completed its integration of Halfpenny Technologies into Accumen Technology Solutions, rebranding HTI's Clinical Data Exchanges, Orders Management Portal, and Clinical Data Services as AccumenConnect products. The integration allows HTI customers to benefit from Accumen's support and implementation excellence without changing application access or updating agreements.